Deep Track Capital, LP Nektar Therapeutics Transaction History
Deep Track Capital, LP
- $2.71 Billion
- Q3 2024
A detailed history of Deep Track Capital, LP transactions in Nektar Therapeutics stock. As of the latest transaction made, Deep Track Capital, LP holds 15,922,655 shares of NKTR stock, worth $15.1 Million. This represents 0.76% of its overall portfolio holdings.
Number of Shares
15,922,655
Previous 17,875,498
10.92%
Holding current value
$15.1 Million
Previous $22.2 Million
6.61%
% of portfolio
0.76%
Previous 0.73%
Shares
5 transactions
Others Institutions Holding NKTR
# of Institutions
145Shares Held
139MCall Options Held
32.6KPut Options Held
14.1K-
Black Rock Inc. New York, NY15.2MShares$14.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.1MShares$12.5 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA9.4MShares$8.93 Million0.22% of portfolio
-
Samlyn Capital, LLC New York, NY9.2MShares$8.74 Million0.19% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il6.95MShares$6.61 Million0.0% of portfolio
About NEKTAR THERAPEUTICS
- Ticker NKTR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 187,404,992
- Market Cap $178M
- Description
- Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...